Avidity Biosciences
RNA
#2594
Rank
C$7.75 B
Marketcap
$64.99
Share price
-1.66%
Change (1 day)
759.46%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of June 2024 : C$1.80 Billion

According to Avidity Biosciences's latest financial reports the company has C$1.80 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.78 B-4.72%
2022-12-31C$0.82 B60.34%
2021-12-31C$0.51 B23.53%
2020-12-31C$0.41 B238.72%
2019-12-31C$0.12 B2834.63%
2018-12-31C$4.2 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$1.52 B-15.84%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.02 M-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.03 B 12.43%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.52 B-71.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.42 B-76.53%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.87 B 446.63%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.98 B 230.91%๐Ÿ‡ฌ๐Ÿ‡ง UK